Publications by authors named "Bogac Aybey"

Unlabelled: Epithelial-to-mesenchymal transition (EMT) in cancer cells confers migratory abilities, a crucial aspect in the metastasis of tumors that frequently leads to death. In multiple studies, authors proposed gene expression signatures for EMT, stemness, or mesenchymality of tumors based on bulk tumor expression profiling. However, recent studies suggested that noncancerous cells from the microenvironment or macroenvironment heavily influence such signature profiles.

View Article and Find Full Text PDF

Background: Robust immune cell gene expression signatures are central to the analysis of single cell studies. Nearly all known sets of immune cell signatures have been derived by making use of only single gene expression datasets. Utilizing the power of multiple integrated datasets could lead to high-quality immune cell signatures which could be used as superior inputs to machine learning-based cell type classification approaches.

View Article and Find Full Text PDF
Article Synopsis
  • Pazopanib is a multi-receptor tyrosine kinase inhibitor approved for advanced soft-tissue sarcoma, but its effectiveness varies widely among patients, with no established predictors for who will benefit.
  • In a study involving 109 pazopanib-treated sarcoma patients, specific genetic alterations did not correlate with clinical outcomes, but a subcohort of 62 patients showed that certain mRNA levels (NTRK3, IGF1R, KDR) were linked to better progression-free survival.
  • The researchers developed a pazopanib efficacy predictor based on these genetic markers, which successfully distinguished patient groups with significantly different survival outcomes in both an initial and an independent cohort.
View Article and Find Full Text PDF

Copy number alterations constitute important phenomena in tumor evolution. Whole genome single-cell sequencing gives insight into copy number profiles of individual cells, but is highly noisy. Here, we propose CONET, a probabilistic model for joint inference of the evolutionary tree on copy number events and copy number calling.

View Article and Find Full Text PDF

Background: Soft-tissue sarcomas (STS) are a heterogeneous group of mesenchymal tumors for which response to immunotherapies is not well established. Therefore, it is important to risk-stratify and identify STS patients who will most likely benefit from these treatments.

Results: To reveal shared and distinct methylation signatures present in STS, we performed unsupervised deconvolution of DNA methylation data from the TCGA sarcoma and an independent validation cohort.

View Article and Find Full Text PDF